# Safety Trial of Naproxen Sodium/ Diphenhydramine

> **NCT01365052** · PHASE3 · COMPLETED · sponsor: **Bayer** · enrollment: 326 (actual)

## Conditions studied

- Pain

## Interventions

- **DRUG:** Naproxen sodium 440 mg/DPH 50 mg (BAY98-7111)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01365052
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-05
- **Primary completion:** 2011-07
- **Final completion:** 2011-07
- **Target enrollment:** 326 (ACTUAL)
- **Last updated:** 2015-06-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01365052

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01365052, "Safety Trial of Naproxen Sodium/ Diphenhydramine". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01365052. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*